InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Joshi Manher. Officer active across 2 companies, notably Atara Biotherapeutics, Inc.. In total, 4 reports have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €9k. Activity tracked since 16 August 2023. The latest transaction was disclosed on 21 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Joshi Manher is Chief Development Officer at Soleno Therapeutics INC and EVP, Chief Medical Officer at Atara Biotherapeutics, Inc. The record shows 4 filings in total, and across the 4 recent filings available, the activity spans from 2023-08-18 to 2026-01-23, with EUR 0 of purchases and EUR 9267 of sales; the most frequent transaction nature is Attribution.